대한두경부종양학회지 (Korean Journal of Head & Neck Oncology)

  • 제39권2호
  • /
  • Pages.1-6
  • /
  • 2023
  • /
  • 1229-5183(pISSN)
  • /
  • 2586-2553(eISSN)
대한두경부종양학회 (The Korean Society for Head and Neck Oncology)
권호 표지
DOI QR코드

DOI QR Code

노인 두경부암 환자의 생존에 있어 노쇠의 의의

Frailty in Geriatric Patients with Head and Neck Cancer and its Implication in Survivorship

  • 권민수 (울산대학교 의과대학 서울아산병원 이비인후과-두경부외과)
  • Minsu Kwon (Department of Otolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2023.11.15
  • 심사 : 2023.11.25
  • 발행 : 2023.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The aging population, particularly those aged 65 and above, is on the rise, with projections indicating a substantial increase in the elderly demographic. This demographic shift brings challenges in managing age-related diseases, including head and neck cancers (HNCs). Frailty, often characterized by physiological decline and vulnerability to stressors, is a crucial factor affecting treatment outcomes of elderly cancer patients. Accordingly, the significance of assessing frailty in elderly HNC patients before their treatment should be emphasized, but current frailty assessment tools may not fully capture the unique challenges faced by HNC patients. Specific indicators, including respiratory and swallowing functions, are proposed for a more tailored assessment. This comprehensive review explores the impact of frailty on various treatment modalities, including surgery, radiation, and chemotherapy, highlighting the need for personalized interventions. Furthermore, it suggests avenues for future research to enhance frailty assessment tools and investigate interventions aimed at improving treatment outcomes in elderly HNC patients.

키워드

과제정보

This work is supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT (RS-2023-00208625) of Korea.

참고문헌

  1. Statistics Korea. 2022 elderly population statistics. Available from: URL: https://kostat.go.kr/board.es?mid=a10301060500&bid=10820&act=view&list_no=420896&tag=&nPage=1&ref_bid= 
  2. Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022;54:330-344. 
  3. Thompson-Harvey A, Yetukuri M, Hansen AR, Simpson MC, Adjei Boakye E, Varvares MA, et al. Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2020;126:1090-1101. 
  4. Guo K, Xiao W, Chen X, Zhao Z, Lin Y, Chen G. Epidemiological trends of head and neck cancer: A population-based study. Biomed Res Int. 2021;2021:1738932. 
  5. Walston J, Hadley EC, Ferrucci L, Guralnik JM, Newman AB, Studenski SA, et al. Research agenda for frailty in older adults: Toward a better understanding of physiology and etiology: Summary from the American geriatrics society/national institute on aging research conference on frailty in older adults. J Am Geriatr Soc. 2006;54:991-1001. 
  6. Xue QL. The frailty syndrome: Definition and natural history. Clin Geriatr Med. 2011;27:1-15. 
  7. VanderWalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: A review. Oncologist. 2013;18:568-578. 
  8. Kwon M, Kim SA, Roh JL, Lee SW, Kim SB, Choi SH, et al. An introduction to a head and neck cancer-specific frailty index and its clinical implications in elderly patients: A prospective observational study focusing on respiratory and swallowing functions. Oncologist. 2016;21:1091-1098. 
  9. Zwart AT, van der Hoorn A, van Ooijen PMA, Steenbakkers R, de Bock GH, Halmos GB. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer. J Cachexia Sarcopenia Muscle. 2019;10:1060-1069. 
  10. Meerkerk CDA, Chargi N, de Jong PA, van den Bos F, de Bree R. Sarcopenia measured with handgrip strength and skeletal muscle mass to assess frailty in older patients with head and neck cancer. J Geriatr Oncol. 2021;12:434-440. 
  11. Meerkerk CDA, Chargi N, de Jong PA, van den Bos F, de Bree R. Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients. Eur Arch Otorhinolaryngol. 2022;279:967-977. 
  12. Dewansingh P, Bras L, Ter Beek L, Krijnen WP, Roodenburg JLN, van der Schans CP, et al. Malnutrition risk and frailty in head and neck cancer patients: Coexistent but distinct conditions. Eur Arch Otorhinolaryngol. 2023;280:1893-1902. 
  13. Ku JY, Roh JL, Kim SB, Choi SH, Nam SY, Kim SY. Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer. J Geriatr Oncol. 2020;11:417-422. 
  14. Mady LJ, De Ravin E, Vohra V, Lu J, Newman JG, Hall DE, et al. Exploring olfactory dysfunction as a marker of frailty and postoperative outcomes in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2023;149:828-836. 
  15. Noor A, Gibb C, Boase S, Hodge JC, Krishnan S, Foreman A. Frailty in geriatric head and neck cancer: A contemporary review. Laryngoscope. 2018;128:E416-e424. 
  16. Palmer K, Onder G. Comprehensive geriatric assessment: Benefits and limitations. Eur J Intern Med. 2018;54:e8-e9. 
  17. Pandey Y, Pandey B, Aurit SJ, Militsakh O, Lydiatt W, Lydiatt D, et al. Evaluation of agreement among frailty assessment tools in head and neck surgery. Otolaryngol Head Neck Surg. 2023;168:32-38. 
  18. Raab G, Restifo D, McBride SM, Wong RJ, Lee NY, Shahrokni A, et al. Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment. J Geriatr Oncol. 2022;13:228-233. 
  19. Matos LL, Sanabria A, Robbins KT, Halmos GB, Strojan P, Ng WT, et al. Management of Older Patients with Head and Neck Cancer: A Comprehensive Review. Adv Ther. 2023;40:1957-1974. 
  20. Mady LJ, Baddour K, Hodges JC, Magana LC, Schwarzbach HL, Borrebach JD, et al. The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm. Oral Oncol. 2022;126:105766. 
  21. Fahy E, Cantwell LA, Patterson JM, Cherry MG, Rogers S, Akpan A, et al. Treatment priorities and regret in older adults with head and neck cancer: A systematic review. Clin Otolaryngol. 2023;48:809-819. 
  22. Pitts KD, Arteaga AA, Stevens BP, White WC, Su D, Spankovich C, et al. Frailty as a predictor of postoperative outcomes among patients with head and neck cancer. Otolaryngol Head Neck Surg. 2019;160:664-671. 
  23. Goldstein DP, Sklar MC, de Almeida JR, Gilbert R, Gullane P, Irish J, et al. Frailty as a predictor of outcomes in patients undergoing head and neck cancer surgery. Laryngoscope. 2020;130:E340-e345. 
  24. Han SH, Cho D, Mohammad R, Jung YH, Ahn SH, Cha W, et al. Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer. Head Neck. 2022;44:672-680. 
  25. Wang Y, Zheng Y, Wen Z, Zhou Y, Wang Y, Huang Z. Effects of frailty on patients undergoing head and neck cancer surgery with flap reconstruction: A retrospective analysis. BMJ Open. 2022;12:e062047. 
  26. Kapoor D, Cleere EF, Hurley CM, de Blacam C, Theopold CFP, Beausang E. Frailty as a predictor of adverse outcomes in head and neck reconstruction: A systematic review. J Plast Reconstr Aesthet Surg. 2023;77:328-338. 
  27. Thomas CM, Sklar MC, Su J, Xu W, De Almeida JR, Alibhai SMH, et al. Longitudinal assessment of frailty and quality of life in patients undergoing head and neck surgery. Laryngoscope. 2021;131:E2232-e2242. 
  28. Fu TS, Sklar M, Cohen M, de Almeida JR, Sawka AM, Alibhai SMH, et al. Is frailty associated with worse outcomes after head and neck surgery? A narrative review. Laryngoscope. 2020;130:1436-1442. 
  29. Rothman S, Zabarqa S, Pitaro J, Gavriel H, Marom T, Muallem Kalmovich L. Head and neck cancer surgery in elderly patients: The role of frailty assessment. Eur Arch Otorhinolaryngol. 2023;280:1447-1453. 
  30. Bras L, de Vries J, Festen S, Steenbakkers R, Langendijk JA, Witjes MJH, et al. Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study. Oral Oncol. 2021;118:105329. 
  31. de Vries J, Poelman A, Sidorenkov G, Festen S, de Bock GH, Langendijk JA, et al. The association of frailty and outcomes of geriatric assessment with acute radiation-induced toxicity in patients with head and neck cancer. Oral Oncol. 2022;130:105933. 
  32. Szturz P, Bossi P, Vermorken JB. Systemic treatment in elderly head and neck cancer patients: Recommendations for clinical practice. Curr Opin Otolaryngol Head Neck Surg. 2019;27:142-150. 
  33. Iqbal MS, Dua D, Kelly C, Bossi P. Managing older patients with head and neck cancer: The non-surgical curative approach. J Geriatr Oncol. 2018;9:411-417. 
  34. Bras L, Driessen D, de Vries J, Festen S, van der Laan B, van Leeuwen BL, et al. Patients with head and neck cancer: Are they frailer than patients with other solid malignancies? Eur J Cancer Care (Engl). 2020;29:e13170. 
  35. van Deudekom FJ, Schimberg AS, Kallenberg MH, Slingerland M, van der Velden LA, Mooijaart SP. Functional and cognitive impairment, social environment, frailty and adverse health outcomes in older patients with head and neck cancer, a systematic review. Oral Oncol. 2017;64:27-36. 
  36. Voora RS, Qian AS, Kotha NV, Qiao EM, Meineke M, Murphy JD, et al. Frailty index as a predictor of readmission in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2022;167:89-96. 
  37. Imam T, Konstant-Hambling R, Flint H, Brooks TA, Patel NN, Conroy S. The hospital frailty risk score and outcomes in head and neck cancer surgery. Clin Otolaryngol. 2023;48:604-612.